THALASSEMIA in ASIA 2021: Thalassemia in Guangxi Province, People’s Republic of China
Ping Chen, Weixiong Lin, Shu-Qun Li
Abstract
Guangxi Province is located in the southwest of the People's Republic of China (PRC). The province has a population of 50.12 million with a birth rate of 13.31%. Thalassemia is a major health problem in Guangxi Province. About 20.0-25.0% of the population carries thalassemia genes, which is acknowledged to be the highest prevalence in China. National and provincial programs for thalassemia prevention and control have been introduced. Premarital screening and prenatal diagnosis (PND) for the prevention of thalassemic fetuses are available. Blood transfusions, iron chelation therapy, and stem cell transplantation are also available for transfusion-dependent thalassemic patients.
Topics & Concepts
ThalassemiaChinaPopulationMedicinePrenatal diagnosisChelation therapyBeta thalassemiaPediatricsGeographyEnvironmental healthTraditional medicineFetusPregnancyBiologyInternal medicineGeneticsArchaeologyHemoglobinopathies and Related DisordersPrenatal Screening and DiagnosticsIron Metabolism and Disorders